Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT®-Lung Test

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Macdonald, Isabel K ^a   Murray, Andrea ^a   Healey, Graham F ^a   Parsy Kowalska, Celine B ^a   Allen, Jared ^a   McElveen, Jane ^a   Robertson, Chris ^b   Sewell, Herbert F ^a,c   Chapman, Caroline J ^a,c   Robertson, John F R ^a,c  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; ONCOPROTEIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CANCER SCREENING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PREDICTIVE VALUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CLONING, MOLECULAR; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; RISK; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84871310263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051002     Document Type: Article

References (29)

1. Baldwin RW, (1966) Tumour-specific immunity against spontaneous rat tumours. Int J Cancer 1: 257-64.
2. Desmetz C, Mange A, Maudelonde T, Solassol J, (2011) Autoantibody signatures: progress and perspectives for early detection. J Cell Mol Med 15: 2013-24.
3. Aberle DR, Addams AM, Berg CD, Black WC, Clapp JD, et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med 365: 395-409.
4. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, et al. (2005) CT screening for lung cancer: five-year prospective experience. Radiology 235: 259-65.
5. van Klaveren RJ, (2009) Lung cancer screening with low dose computed tomography: where do we stand today? Eur J Cancer 45: 375-6.
6. Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, et al. (2010) Technical validation of an autoantibody test for lung cancer. Ann Oncol 21: 1687-93.
7. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, et al. (2011) Clinical validation of an autoantibody test for lung cancer. Ann Oncol 22: 383-9.
8. Lam S, Boyle P, Healey G, Maddison P, Peek L, et al. (2011) EarlyCDT-Lung: an immuno-biomarker test as an aid to early detection of lung cancer. Cancer Prev Res 4: 1126-34.
9. Chapman CJ, Healey G, Murray A, Boyle P, Robertson C, et al. (2012) EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumor Biol 2012 Apr 11. Epub ahead of print PMID 22492236.
10. Jett JR, Jewell W, Robertson JF, (2011) EarlyCDT™-Lung test: audit of the first 1000 patients in clinical practice. J Thoracic Oncol 6: S1387-8.
11. Krause P, Tureci O, Micke P, Buhl R, Huber C, et al. (2003) SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity. J Immunol Meth 283: 261-7.
12. Canelle L, Bousquet J, Pionneau C, Deneux L, Sghiouar N, et al. (2005) An efficient proteomics-based approach for the screening of autoantibodies. J Immunol Meth 299: 77-89.
13. Macdonald IK, Allen J, Murray A, Parsy-Kowalska CB, Healey GF, et al. (2012) Development and validation of a high throughput system for discovery of antigens for autoantibody detection. Available http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0040759. Accessed 30th July 2012.
14. Aslanidis C, de Jong PJ, (1990) Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res 18: 6069-74.
15. Parsy CB, Chapman CJ, Barnes AC, Robertson JF, Murray A, (2007) Two step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. J Chromatog B Anal Technol Biomed Life Sci 853: 314-19.
16. Geyer C (1999) Estimation and otpimization of functions. In Gilks WR, Richardson ST, Speigelhalter DJ (eds). Markov Chain Monte Carlo in Practise. London: Chapman and Hall 241-58.
17. Subramanian A, Miller DM, (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275: 5958-65.
18. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, et al. (2007) High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy. J Neuroimmunol 185: 195-200.
19. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, et al. (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 48: 2025-35.
20. Nahm DH, Lee KH, Shin JY, Ye YM, Kang Y, et al. (2006) Identification of alpha-enolase as an autoantigen associated with severe asthma. J Allergy Clin Immunol 118: 376-81.
21. Hembrough TA, Vasudevan J, Allietta MM, Glass WF, Gonias SL, (1995) A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, hepg2 cells and breast-carcinoma cell-lines. J Cell Sci 108: 1071-82.
22. Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, et al. (2006) New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol 39: 8-13.
23. Leong A S-Y, Cooper K, Leong F, Joel W-M (2003) Manual of Diagnostic Cytology (2nd ed). Greenwich Medical Media, Ltd. pp. 177-178.
24. Moll R, Zimbelmann R, Goldschmidt MD, Keith M, Laufer J, et al. (1993) The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53: 75-93.
25. Moll R, Schiller DL, Franke WW, (1990) Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and exression patterns. J Cell Biol 111: 567-80.
26. Moll R, Lowe A, Laufer J, Franke WW, (1992) Cytokeratin-20 in human carniomas - a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140: 427-47.
27. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, et al. (1985) L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318: 69-73.
28. Ingvarsson S, (1990) The myc gene family proteins and their role in transformation and differentiation. Sem Cancer Biol 1: 359-69.
29. Robertson NG, Pomponio RJ, Mutter GL, Morton CC, (1991) Testis-specific expression of the human MYCL2 gene. Nucleic Acid Residues 19 (11):: 3129-37.